Reimbursement

September 16th 2024

For biosimilars to overcome these entrenched market dynamics, they must not only compete on price but actively work to build a network of support among providers and patients.

August 21st 2024

The decision by the Supreme Court has the potential to upend the power of regulatory agencies to shape the health care landscape of the country.

August 15th 2024

The new prices are expected to go into effect for patients with Medicare Part D on January 1, 2026.

August 12th 2024

Investigators find that this could suggest the biosimilar uptake alone may not be a complete measure of the market competition and lowering prices.